We provide 1 form of Selinexor
Selinexor
1393477-72-9
|
443.093
|
2.68
Selinexor is a first-in-class selective inhibitor of nuclear transport compound. It binds to and inhibits exportin-1 (XPO1). Selinexor is indicated in combination with bortezomib and dexamethasone for the treatment of multiple myeloma in adult patients who have received at least one prior therapy.
KPT-330 | selinexor
Selinexor is a first-in-class selective inhibitor of nuclear transport compound. It binds to and inhibits exportin-1 (XPO1). Selinexor is indicated in combination with bortezomib and dexamethasone for the treatment of multiple myeloma in adult patients who have received at least one prior therapy.
KPT-330 | selinexor
$89/5 mg
(EBC)
1
We provide 0 compound for Selinexor